Skip to content

Continuous ? rhythm stimulation and low frequency repetitive transcranial magnetic stimulation on Comparative study on the efficacy of upper limb motor function in subacute stroke patients

Continuous ? rhythm stimulation and low frequency repetitive transcranial magnetic stimulation on Comparative study on the efficacy of upper limb motor function in subacute stroke patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091490
Enrollment
Unknown
Registered
2024-10-29
Start date
2023-12-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper limb motor dysfunction after stroke

Interventions

cTBS group:Stimulation site: The coil is tangential to the skull and acts on the M1 region of the healthy hemisphere. Treatment parameters: cTBS treatment mode was selected for transcranial magnetic s
Low frequency rTMS group:Stimulation site: The coil is tangential to the skull and acts on the M1 region of the healthy hemisphere. Treatment parameters: Low frequency rTMS treatment mode was selected
sham stimulation group:The coil was placed in the M1 region of the healthy hemisphere perpendicular to the skull, and the remaining parameters were set according to the low-frequency rTMS treatment. T

Sponsors

Qingdao Central Medical Group
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the stroke diagnostic criteria formulated by the 6th National Conference on Cerebrovascular Diseases, and the first ischemic stroke or hemorrhagic stroke is confirmed by MRI or CT examination. (2) 2 weeks to 3 months after stroke, aged 45-75 years; (3) Accompanied by unilateral upper limb motor dysfunction, Brunnstrom stage II-V; (4) No serious cognitive and speech dysfunction, MMSE=26, can cooperate with the completion of treatment and evaluation; (5) Patients and their families participate voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Complicated with heart, lung, liver, kidney, endocrine and other serious basic diseases and mental diseases; (2) can not tolerate cTBS or low-frequency rTMS treatment; (3) Patients with contraindications to rTMS (wearing pacemakers, intracranial metal implants, and other internal metal implants); (4) have received antispasmodic therapy or botox injection in the upper limb in a short period of time; (5)Can not cooperate with evaluation or treatment for various reasons.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer upper limb motor function scale;Wolf Motor Function Test Scale;Modified Barthel index scale;

Secondary

MeasureTime frame
neuro-electrophysiology;

Countries

China

Contacts

Public ContactShaoping Lv

Qingdao Central Medical Group

liu0726@qq.com+86 182 5425 8887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026